The Concomitant Therapy of Direct Oral Anticoagulants with Amiodarone in Atrial Fibrillation: A Meta-analysis
Background The concomitant therapy of amiodarone with direct oral anticoagulants (DOACs) significantly increases the concentrations of DOACs and may increase the bleeding risks. Multiple real-world studies compared the concomitant therapy of amiodarone and DOACs versus the DOAC alone, but their main...
Saved in:
| Main Authors: | Kazuhiko Kido PharmD, PhD, Mikiko Shimizu PhD, Tsuyoshi Shiga MD, PhD, Masayuki Hashiguchi PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Journal of Cardiovascular Pharmacology and Therapeutics |
| Online Access: | https://doi.org/10.1177/10742484251351148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stroke Prevention With Oral Anticoagulants in High-Risk Atrial Fibrillation in an Aging Population
by: Ken Okumura, MD, PhD, et al.
Published: (2025-06-01) -
Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
by: Sibylle Frerebeau PharmD, et al.
Published: (2025-06-01) -
140 Impact of Amiodarone Exposure on Apixaban Pharmacokinetics in Hospitalized Patients
by: Samantha Kolowrat, BS, et al.
Published: (2025-05-01) -
Knockdown of AMFR Alleviates Atrial Fibrosis in Atrial Fibrillation by Stabilizing SOD1 Protein Expression
by: Shanshan Geng MD, et al.
Published: (2025-07-01) -
Prevalence of Atrial Fibrillation and Long-Term Survival of Older Adults; Findings from the SNAC Study
by: Terese Lindberg PhD, et al.
Published: (2024-12-01)